Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide-1 Receptor Agonist in Chinese Patients with Type 2 Diabetes Mellitus
posted on 2021-05-25, 17:27authored byXiaoling Cai, Linong Ji
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).